1:00 - 3:00 PM: Diabetes in Qatar:
Chairs: Dr. Abdul Badi Abou-Samra and Dr.Shaimaa Arroub
- 1:00 - 1:30: Whole Genome Sequencing Approach to Define the Genetic Risks of Diabetes in Qatar, a Population Based Study: Dr. Omar Albagha
- 1:30 - 2:00: Molecular and Clinical Phenotypes of Diabetes Subgroups in the Qatar Biobank: An Update From the Qatar Diabetes Prevention Program Research Cluster: Dr. Karsten Suhre
- 2:00 - 2:30: Reversal of Early Diabetes in Qatar – What is Next?: Dr. Sharad Taheri
- 2:30- 3:00: Panel Discussion
3:00 - 3:30: Prayer and Coffee Break
3:30 - 4:15: Platinum Lecture
(Non-CPD accredited)
Chair: Dr. Amin Jayyousi Advancing basal insulin therapy in the SoliMix trial: Comparing iGlarLixi to premix insulin: Dr. Juan Pablo Frias
4:15 - 5:30 pm: Two Parallel Sessions
Session one:
Learning objective: managing patients on glucocorticoids replacement
Chair: Dr. Khaled Dukhan
- 4:15 - 4:50 : Monitoring Patients on Steroid Replacement: Dr. Richard J. Auchus
-
4:50 - 5:30: Gold lecture (Non-CPD accredited)
CGM in Practice: Insights for guiding consultations in T2D: Dr. Iskandar Idris
Session Two:
Learning objective: endocrine causes of hypertension
Chairs: Dr. Wissam Ghadban
-
4:15 - 4:50 : Pheochromocytoma and Paraglionoma: Dr. William Young
-
4:50 - 5:30: Gold lecture
(Non-CPD accredited)
Empagliflozin in HF Across All Ejection Fraction: Dr Salah El Badri
5:30 - 6:00 pm: Prayer and Coffee Break
6:00 - 7:00 pm: Plenary 2
Learning objective: Individualization of patients’ management
Chair: Dr. Abdul Wajid Safi
Precision Medicine in Endocrine and Diabetes: Dr.Ewan Pearson
